Mediwhale Raises 20 Billion Won and Heads to FDA(venturesquare.net)
Writing language: KoreanRead in the original language
Plain summary
- Mediwhale has secured 20 billion won in Series C funding.
- The investment will be used to pursue U.S. FDA approval for the cardiovascular diagnostic device Dr. NUN CVD and to expand domestic and international markets.
- This serves as a case for medical device founders to consider how early product development and regulatory preparation should be aligned when planning overseas expansion.
- If clinical data needs to be re-prepared after checking approval requirements right before launch, financial plans can also become complicated.
Have you run into something like this? Tell us in a line or two what you did. You do not need to know the product.